Limited cutaneous systemic sclerosis
ICD-10 M34.1 · ICD-11 4A42.2

Treatment of Limited Cutaneous Systemic Sclerosis with Small Intestinal Bacterial Overgrowth

This protocol addresses patients with limited cutaneous systemic sclerosis (lcSSc) who also have small intestinal bacterial overgrowth (SIBO) — a recognised gastrointestinal complication in this population.

Treatment Approach

The approach to SIBO in lcSSc involves a rotational antibiotic strategy. The full selection criteria, sequencing, and clinical decision pathway are available in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1136/ard-2024-226430

The use of rotating antibiotics should be considered for the treatment of small intestinal bacterial overgrowth.

View source ↗